These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16221839)

  • 21. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease.
    Zhao R; Hu W; Tsai J; Li W; Gan WB
    Mol Neurodegener; 2017 Jun; 12(1):47. PubMed ID: 28606182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing times for the "amyloid cascade hypothesis".
    Hardy J
    Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803
    [No Abstract]   [Full Text] [Related]  

  • 23. Amyloid beta vaccination: reduced plaques and improved cognition.
    Younkin SG
    Nat Med; 2001 Jan; 7(1):18-9. PubMed ID: 11135604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual severity of AD-type lesions, Aß oligomers, and comorbidity in the brain aging.
    Bouras C; Kovari E; Savioz A; Giacobini E; Xekardaki A
    Adv Exp Med Biol; 2015; 822():17. PubMed ID: 25416972
    [No Abstract]   [Full Text] [Related]  

  • 25. State of aggregation.
    Nat Neurosci; 2011 Apr; 14(4):399. PubMed ID: 21445061
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-amyloid plaques induce neuritic dystrophy of nitric oxide-producing neurons in a transgenic mouse model of Alzheimer's disease.
    Quinn J; Davis F; Woodward WR; Eckenstein F
    Exp Neurol; 2001 Apr; 168(2):203-12. PubMed ID: 11259108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New plaque-boosting protein a possible Alzheimer target.
    Voelker R
    JAMA; 2010 Oct; 304(13):1431. PubMed ID: 20924003
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.
    Hock C; Konietzko U; Streffer JR; Tracy J; Signorell A; Müller-Tillmanns B; Lemke U; Henke K; Moritz E; Garcia E; Wollmer MA; Umbricht D; de Quervain DJ; Hofmann M; Maddalena A; Papassotiropoulos A; Nitsch RM
    Neuron; 2003 May; 38(4):547-54. PubMed ID: 12765607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.
    Smith LM; Strittmatter SM
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions?
    Savory J; Ghribi O; Herman MM
    Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807
    [No Abstract]   [Full Text] [Related]  

  • 32. Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
    Audrain M; Fol R; Dutar P; Potier B; Billard JM; Flament J; Alves S; Burlot MA; Dufayet-Chaffaud G; Bemelmans AP; Valette J; Hantraye P; Déglon N; Cartier N; Braudeau J
    Mol Neurodegener; 2016 Jan; 11():5. PubMed ID: 26759118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease.
    Gamage KK; Kumar S
    J Neurosci; 2017 Apr; 37(17):4430-4432. PubMed ID: 28446659
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
    Wiley JC; Pettan-Brewer C; Ladiges WC
    Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
    Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
    ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of haemolytic and oligomer-preventing activities of gramicidin S derivatives targeting the amyloid-β N-terminus.
    Chen D; Qin W; Wen G; Shi B; Liu Z; Wang Y; Zhou Q; Quan J; Zhou B; Bu X
    Chem Commun (Camb); 2017 Dec; 53(100):13340-13343. PubMed ID: 29188836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-dependent and amyloid-independent stages of Alzheimer disease.
    Hyman BT
    Arch Neurol; 2011 Aug; 68(8):1062-4. PubMed ID: 21482918
    [No Abstract]   [Full Text] [Related]  

  • 39. Bioflocculant hypothesis: a partial endorsement.
    Terry R
    Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804
    [No Abstract]   [Full Text] [Related]  

  • 40. Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function.
    Lesné S; Kotilinek L; Ashe KH
    Neuroscience; 2008 Feb; 151(3):745-9. PubMed ID: 18155846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.